BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 27911471)

  • 1. The effects of coenzyme Q10 supplementation on glucose metabolism and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
    Samimi M; Zarezade Mehrizi M; Foroozanfard F; Akbari H; Jamilian M; Ahmadi S; Asemi Z
    Clin Endocrinol (Oxf); 2017 Apr; 86(4):560-566. PubMed ID: 27911471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of zinc supplementation on markers of insulin resistance and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
    Foroozanfard F; Jamilian M; Jafari Z; Khassaf A; Hosseini A; Khorammian H; Asemi Z
    Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):215-20. PubMed ID: 25868059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of coenzyme Q10 administration on glucose homeostasis parameters, lipid profiles, biomarkers of inflammation and oxidative stress in patients with metabolic syndrome.
    Raygan F; Rezavandi Z; Dadkhah Tehrani S; Farrokhian A; Asemi Z
    Eur J Nutr; 2016 Dec; 55(8):2357-2364. PubMed ID: 26385228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome.
    Asemi Z; Foroozanfard F; Hashemi T; Bahmani F; Jamilian M; Esmaillzadeh A
    Clin Nutr; 2015 Aug; 34(4):586-92. PubMed ID: 25300649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effects of Coenzyme Q10 Supplementation on Glucose Metabolism, Lipid Profiles, Inflammation, and Oxidative Stress in Patients With Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Gholnari T; Aghadavod E; Soleimani A; Hamidi GA; Sharifi N; Asemi Z
    J Am Coll Nutr; 2018; 37(3):188-193. PubMed ID: 29111905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic response to selenium supplementation in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
    Jamilian M; Razavi M; Fakhrie Kashan Z; Ghandi Y; Bagherian T; Asemi Z
    Clin Endocrinol (Oxf); 2015 Jun; 82(6):885-91. PubMed ID: 25510442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonal and Metabolic Effects of Coenzyme Q10 and/or Vitamin E in Patients With Polycystic Ovary Syndrome.
    Izadi A; Ebrahimi S; Shirazi S; Taghizadeh S; Parizad M; Farzadi L; Gargari BP
    J Clin Endocrinol Metab; 2019 Feb; 104(2):319-327. PubMed ID: 30202998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trial of the effects of coenzyme Q10 supplementation on glycemic control and markers of lipid profiles in diabetic hemodialysis patients.
    Fallah M; Askari G; Soleimani A; Feizi A; Asemi Z
    Int Urol Nephrol; 2018 Nov; 50(11):2073-2079. PubMed ID: 30251010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of melatonin administration on mental health parameters, metabolic and genetic profiles in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial.
    Shabani A; Foroozanfard F; Kavossian E; Aghadavod E; Ostadmohammadi V; Reiter RJ; Eftekhar T; Asemi Z
    J Affect Disord; 2019 May; 250():51-56. PubMed ID: 30831541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probiotic supplementation and the effects on weight loss, glycaemia and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
    Ahmadi S; Jamilian M; Karamali M; Tajabadi-Ebrahimi M; Jafari P; Taghizadeh M; Memarzadeh MR; Asemi Z
    Hum Fertil (Camb); 2017 Dec; 20(4):254-261. PubMed ID: 28142296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effects of Flaxseed Oil Omega-3 Fatty Acids Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Mirmasoumi G; Fazilati M; Foroozanfard F; Vahedpoor Z; Mahmoodi S; Taghizadeh M; Esfeh NK; Mohseni M; Karbassizadeh H; Asemi Z
    Exp Clin Endocrinol Diabetes; 2018 Apr; 126(4):222-228. PubMed ID: 29117618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic response to folate supplementation in overweight women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial.
    Asemi Z; Karamali M; Esmaillzadeh A
    Mol Nutr Food Res; 2014 Jul; 58(7):1465-73. PubMed ID: 24828019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effects of Synbiotic Supplementation on Metabolic Status in Women With Polycystic Ovary Syndrome: a Randomized Double-Blind Clinical Trial.
    Samimi M; Dadkhah A; Haddad Kashani H; Tajabadi-Ebrahimi M; Seyed Hosseini E; Asemi Z
    Probiotics Antimicrob Proteins; 2019 Dec; 11(4):1355-1361. PubMed ID: 29532416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of coenzyme Q10 supplementation on gene expression related to insulin, lipid and inflammation in patients with polycystic ovary syndrome.
    Rahmani E; Jamilian M; Samimi M; Zarezade Mehrizi M; Aghadavod E; Akbari E; Tamtaji OR; Asemi Z
    Gynecol Endocrinol; 2018 Mar; 34(3):217-222. PubMed ID: 28949260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral carnitine supplementation reduces body weight and insulin resistance in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
    Samimi M; Jamilian M; Ebrahimi FA; Rahimi M; Tajbakhsh B; Asemi Z
    Clin Endocrinol (Oxf); 2016 Jun; 84(6):851-7. PubMed ID: 26666519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Jamilian M; Asemi Z
    Ann Nutr Metab; 2015; 67(1):42-8. PubMed ID: 26279073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.
    Taghizadeh S; Izadi A; Shirazi S; Parizad M; Pourghassem Gargari B
    Gynecol Endocrinol; 2021 Jan; 37(1):26-30. PubMed ID: 32544011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Influences of Chromium Supplementation on Glycemic Control, Markers of Cardio-Metabolic Risk, and Oxidative Stress in Infertile Polycystic ovary Syndrome Women Candidate for In vitro Fertilization: a Randomized, Double-Blind, Placebo-Controlled Trial.
    Jamilian M; Zadeh Modarres S; Amiri Siavashani M; Karimi M; Mafi A; Ostadmohammadi V; Asemi Z
    Biol Trace Elem Res; 2018 Sep; 185(1):48-55. PubMed ID: 29307112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic profile in dyslipidemic individuals.
    Zhang P; Yang C; Guo H; Wang J; Lin S; Li H; Yang Y; Ling W
    J Clin Lipidol; 2018; 12(2):417-427.e5. PubMed ID: 29454678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Magnesium and Vitamin E Co-Supplementation on Glycemic Control and Markers of Cardio-Metabolic Risk in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Jamilian M; Sabzevar NK; Asemi Z
    Horm Metab Res; 2019 Feb; 51(2):100-105. PubMed ID: 30286483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.